These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30142826)
1. The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer. Wu B; Zhao S; Sheng Y; Ren L; Song G Medicine (Baltimore); 2018 Aug; 97(34):e11972. PubMed ID: 30142826 [TBL] [Abstract][Full Text] [Related]
2. Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer. Xiao B; Peng J; Zhang R; Xu J; Wang Y; Fang Y; Lin J; Pan Z; Wu X Cancer Manag Res; 2017; 9():701-708. PubMed ID: 29225479 [TBL] [Abstract][Full Text] [Related]
3. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864 [TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer. Zhao M; Xing H; He J; Wang X; Liu Y Pathol Res Pract; 2023 Aug; 248():154687. PubMed ID: 37478522 [TBL] [Abstract][Full Text] [Related]
5. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer. Iwata K; Suzawa K; Hashimoto K; Tanaka S; Shien K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S Jpn J Clin Oncol; 2024 Aug; 54(8):895-902. PubMed ID: 38704243 [TBL] [Abstract][Full Text] [Related]
6. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer. Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma. Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298 [TBL] [Abstract][Full Text] [Related]
8. Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer. Huang Y; Lou XY; Zhu YX; Wang YC; Zhang L; Liu HL; Wang C; Zhan HM; Cheng ZQ; Tan WY; Wang L; Fan XJ Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30867256 [TBL] [Abstract][Full Text] [Related]
9. The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer. Lee KH; Kim EY; Yun JS; Park YL; Do SI; Chae SW; Park CH BMC Cancer; 2018 Oct; 18(1):938. PubMed ID: 30285668 [TBL] [Abstract][Full Text] [Related]
10. The ratio of intratumoral CD15 Watanabe J; Kimura T; Saze Z; Sato N; Kofunato Y; Ishigame T; Okada R; Kenjo A; Kono K; Marubashi S Cancer Rep (Hoboken); 2024 Jun; 7(6):e2099. PubMed ID: 38837676 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Stage I-II Rectal Cancer Patients. Yoshida D; Minami K; Sugiyama M; Ota M; Ikebe M; Morita M; Matsukuma A; Toh Y J Surg Res; 2020 Jan; 245():281-287. PubMed ID: 31421374 [TBL] [Abstract][Full Text] [Related]
12. High intratumoral CD8 Yang Y; Attwood K; Bshara W; Mohler JL; Guru K; Xu B; Kalinski P; Chatta G Prostate; 2021 Jan; 81(1):20-28. PubMed ID: 33085799 [TBL] [Abstract][Full Text] [Related]
13. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer. Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Hirakawa K; Ohira M Cancer Sci; 2018 Apr; 109(4):966-979. PubMed ID: 29464828 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases. Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361 [TBL] [Abstract][Full Text] [Related]
15. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy. Li JJX; Ni SYB; Tsang JYS; Chan WY; Hung RKW; Lui JWH; Ng SWY; Shum LK; Tang YF; Tse GM Histopathology; 2024 Apr; 84(5):810-821. PubMed ID: 38192219 [TBL] [Abstract][Full Text] [Related]
17. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer]. Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334 [TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma. Ha SY; Choi S; Park S; Kim JM; Choi GS; Joh JW; Park CK Virchows Arch; 2020 Dec; 477(6):807-816. PubMed ID: 32483662 [TBL] [Abstract][Full Text] [Related]
19. Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. Portale G; Cavallin F; Valdegamberi A; Frigo F; Fiscon V J Gastrointest Surg; 2018 Sep; 22(9):1611-1618. PubMed ID: 29687424 [TBL] [Abstract][Full Text] [Related]